Cyclopentamine

This classification denotes an adrenergic agent with the molecular formula C9H19N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WB9Q6M8O60, chemically known as 2-cyclopentyl-n,1-dimethylethylamine but generally known as cyclopentamine, which bears US NIH Compound Identifier 7608. European Medicines Agency schedules Cyclopentamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06856MIG. The term CYCLOPENTAMINE is an International Non-Proprietary Name. World Health Organization schedules cyclopentamine in its Anatomical Therapeutic Chemical (ATC) Classification. CYCLOPENTAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cyclopentamine under HS 29213099 and SITC 51453. As of Q4 2014, CYCLOPENTAMINE remains the US FDA Preferred Term for this commodity. Cyclopentamine bears US NLM identifiers UMLS ID C0163082 and NCI Concept Code C81341. SMILES: N(C(CC1CCCC1)C)C.